Find your next paid study

International Spine Study Group FoundationNCT04885244

~$10 – $750

Actual pay is set by the research site.

The Effects of NTX-2001, a Novel TAAR1 Partial Agonist, on Alcohol Consumption in Adults With Alcohol Use Disorder: A Phase 1b, Randomized, Placebo-Controlled, Proof-of-Concept Study

The primary goal of this Phase 1b clinical trial is to evaluate the effects of a novel TAAR1 receptor partial agonist (NTX-2001) in adults with Alcohol Use Dis…

Alcohol Use Disorder

Newleos Therapeutics, Inc.NCT07520292

~$150 – $4,200

Actual pay is set by the research site.

Uncomplicated Urinary Tract Infections

Multicenter, Randomized, Open-label, Active-controlled Study With a Blinded Assessor to Evaluate the Safety and Tolerability of Pivmecillinam Hydrochloride Versus Nitrofurantoin for the Treatment of Female Pediatric Subjects, 12 Years to Less Than 18 Years of Age, With Uncomplicated Urinary Tract Infections

Multicenter, Randomized, Open-label, Active-controlled Study with Blinded Assessor to Evaluate the Safety and Tolerability of Pivmecillinam Hydrochloride versu…

Alembic TherapeuticsNCT07871968

~$75 – $2,800

Actual pay is set by the research site.

Follicular LymphomaMarginal Zone Lymphoma

HM2023-43: A Phase 2 Trial of Tafasitamab in Combination With Lenalidomide+Rituximab in Treatment-naive Follicular Lymphoma and Marginal Zone Lymphoma

The study follows a Simon's two-stage phase II trial design to evaluate the safety and efficacy of tafasitamab added to rituximab and lenalidomide for two trea…

Masonic Cancer Center, University of MinnesotaNCT06792825

~$75 – $2,000

Actual pay is set by the research site.

Squamous Non-small Cell Lung Cancer

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of V940 in Combination With Pembrolizumab and Chemotherapy as First-Line Treatment for Participants With Metastatic Squamous NSCLC (INTerpath-013)

Researchers want to know if intismeran autogene (the study treatment) given with pembrolizumab and chemotherapy can treat metastatic treatment-naive squamous n…

Merck Sharp & Dohme LLCNCT07221474

~$75 – $2,800

Actual pay is set by the research site.

HER2+ Metastatic Breast Cancer

A Single Arm, Open-label Phase Ib/II Study of Asciminib in HER2+ Breast Cancer Brain Metastases (ASCENdANT)

The purpose of this study is to evaluate the intracranial response rate of a combination of asciminib/trastuzumab for the treatment of patients with metastatic…

Duke UniversityNCT07136428

~$150 – $3,000

Actual pay is set by the research site.

Observational

Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment

This clinical trial is focused on testing dietary self-monitoring strategies used in behavioral obesity treatment. The goal is to determine which self-monitori…

Obesity & Overweight

The Miriam HospitalNCT07228130

~$10 – $750

Actual pay is set by the research site.

The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry

The STRIDE Registry will evaluate the real-world effectiveness and safety of dupilumab in participants with COPD. The primary objective is to describe characte…

COPD (Chronic Obstructive Pulmonary Disease)

~$10 – $1,125

Actual pay is set by the research site.

SanofiNCT07612878

Observational

The Effectiveness of Carbonate Apatite Bone Graft for Alveolar Ridge Preservation: A Clinical, Radiographic, and Histomorphometric Study

This study will examine whether the use of synthetic carbon apatite bone graft material will lead to more bone formation compared to human derived allograft an…

Healing Wound

University of MichiganNCT07020650

~$10 – $750

Actual pay is set by the research site.

Healthy ParticipantsHepatic Impairment

A Phase 1, Open-Label, Single-Dose, Parallel-Group Study to Evaluate the Pharmacokinetics of Casdatifan (AB521) in Participants With Moderate Hepatic Impairment Compared to Healthy Matched Participants

The purpose of the study is to compare the single dose PK of casdatifan between participants with moderate hepatic impairment (HI) and healthy matched control …

Arcus Biosciences, Inc.NCT07751250

~$500 – $10,500

Actual pay is set by the research site.

Metastatic Pancreatic Cancer

A Phase I, Open-Label, Randomized, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of XNW28012 Monotherapy in the Treatment of Subjects With Metastatic Pancreatic Cancer

A Phase I, Open-Label, Randomized, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of XNW28012 Monotherapy in …

Evopoint Biosciences Inc.NCT07707674

~$150 – $4,200

Actual pay is set by the research site.

Prolactin-Producing Pituitary Tumor

Pasireotide Treatment for Patients With Prolactinomas Who Need Treatment Beyond Dopamine Agonist Therapy

The researchers are doing this study to find out whether pasireotide is an effective treatment for people with prolactinoma who cannot receive dopamine agonist…